chr14-24180539-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_024658.4(IPO4):āc.3149T>Cā(p.Phe1050Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,850 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024658.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IPO4 | NM_024658.4 | c.3149T>C | p.Phe1050Ser | missense_variant | 30/30 | ENST00000354464.11 | NP_078934.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IPO4 | ENST00000354464.11 | c.3149T>C | p.Phe1050Ser | missense_variant | 30/30 | 1 | NM_024658.4 | ENSP00000346453.6 | ||
ENSG00000259522 | ENST00000561419.1 | n.*3776T>C | non_coding_transcript_exon_variant | 31/31 | 2 | ENSP00000454374.1 | ||||
ENSG00000259522 | ENST00000561419.1 | n.*3776T>C | 3_prime_UTR_variant | 31/31 | 2 | ENSP00000454374.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249210Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135264
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461850Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727220
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.3149T>C (p.F1050S) alteration is located in exon 30 (coding exon 30) of the IPO4 gene. This alteration results from a T to C substitution at nucleotide position 3149, causing the phenylalanine (F) at amino acid position 1050 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at